Recent news on

Aggressive Treatment of PSA Recurrences After Primary Treatment Is ...  -  Dec 6, 2006
Cancer Consultants (press release),Currently, only three drugs, Taxotere, Emcyt and Novantrone® (mitoxantrone), are FDA-approved for the treatment of prostate cancer. ...

Aggressive Treatment of PSA Recurrences After Primary Treatment Is ...  -  Dec 6, 2006
Cancer Consultants (press release),Recent publications suggest that Taxotere alone or combined with Emcyt with or without prednisone may be the optimal treatment of hormone-refractory



Taxol® and Paraplatin® Superior to Novantrone® for Hormone ...  Mar 10, 2006
...cancer. However, until recently Novantrone was the drug of choice. The new standard may be Taxotere and Emcyt® (estramustine). The ... - Cancer Consultants

This site is for informational purposes only--it does not offer medical advice or sell health products. If you need assistance, contact your physician or healthcare professional